Effects of zinc-nitrosylpentacyanoferrate on the cardiovascular system.
D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002946:Cisterna Magna; D005260:Female; D005292:Ferricyanides / Q000494:pharmacology* / Q000633:toxicity; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007267:Injections; D008297:Male; D008365:Manometry; D009569:Nitric Oxide / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D013055:Spectrophotometry, Infrared; D013997:Time Factors; D014439:Tyramine / Q000037:antagonists & inhibitors; D015032:Zinc / Q000494:pharmacology / Q000633:toxicity
D000959:Antihypertensive Agents; D005292:Ferricyanides; D009569:Nitric Oxide; D000661:Amphetamine; D015032:Zinc; D014439:Tyramine